Ikena Oncology (IKNA) director Bonita received 17,520 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
David P Bonita (director at Ikena Oncology Inc., IKNA) reported that they received 17,520 Stock Option (Right to Buy) on Jun 7, 2024.
- Reporting person
- Bonita David P
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 7, 2024 | Grant or award (A) | Stock Option (Right to Buy)On 17,520 Common Stock1 | +17,520 | - | - | 17,520 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 17,520 direct
Footnotes from the filing
- 1. This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Bonita report in this IKNA Form 4?
David P Bonita (director at Ikena Oncology Inc., IKNA) reported that they received 17,520 Stock Option (Right to Buy) on Jun 7, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for IKNA
Earlier insider filings at IKNA
- Jun 10, 2024SEC Form 4 filed by Director Hughes Owen
- Jun 10, 2024SEC Form 4 filed by Director Stampacchia Otello
- Jun 10, 2024SEC Form 4 filed by Director Koehler Maria
- Mar 5, 2024SEC Form 4 filed by Germa Caroline
- Feb 2, 2024SEC Form 4 filed by Ecsedy Jeffrey
Keep researching IKNA
- IKNA insider tradesEvery buy and sale reported by Ikena Oncology Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
IKNA
Ikena Oncology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for IKNA
Full IKNA profile on Quantisnow Follow IKNA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time